LTUSLotus Pharmaceuticals, Inc.
EN | 中文

LOTUS PHARMACEUTICALS, INC. | OTC: LTUS

Building a Stronger
Future in Healthcare

We explore partnerships, strategic investments and potential acquisitions with healthcare founders and operators.

EXPLORE OUR STRATEGY

A Platform for Strategic Growth

Leveraging our public company platform to explore opportunities in the healthcare sector through investment, collaboration and potential M&A.

+

Healthcare

We look at how medicines, devices and care services reach clinicians and patients.

▱

Strategic Investment

We consider product maturity, customer demand and operating cash flow when evaluating a business.

♧

M&A Opportunities

We discuss goals, team continuity and operating fit with founders before considering a transaction structure.

Sectors of interest

We are seeking industry partners and potential acquisition opportunities in five areas.

Pharmaceuticals
Development and manufacturing of specialty formulations, improved medicines and active ingredients.
Biopharma
Developers of oncology treatments, antibody therapeutics and recombinant proteins.
Digital health and AI
Software for drug discovery, clinical trials and care delivery, alongside telehealth services.
Devices and diagnostics
In vitro diagnostic reagents, testing equipment, clinical devices and consumables.
Care and research services
Hospitals, specialty providers, senior care, contract research, and contract development and manufacturing.

Company history

The company was incorporated in Nevada on January 28, 2004. It adopted the name Lotus Pharmaceuticals, Inc. on December 7, 2006. Its OTC Markets common stock symbol is LTUS.

Nevada State Business License

Nevada business ID NV20041363347
Certificate number B20261116000403
Issued November 16, 2026
Stated expiration January 31, 2027

View license (PDF) · State certificate lookup

Investor relations

Consult the company’s disclosures for its business activities, financial statements and share information for each reporting period.